Luis E. Fayad - Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

基本信息

Career Trajectory

Bio

Luis E. Fayad has been at M. D. Anderson Cancer Center for over the last 20 years. He holds the position of Professor of Medicine in the Department of Lymphoma/Myeloma. Dr. Fayad has over 100 scientific publications in peer-reviewed journals and his main area of interest is the development of new treatment strategies in the management of large cell lymphoma.

Research Interests

Papers共 573 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

A Phase 2 Study of Obinutuzumab Combined with Lenalidomide in Previously Untreated High Tumor Burden Follicular Lymphoma

Neha Akkad,Lei Feng, Jason R Westin,Fredrick B Hagemeister,Hun Ju Lee,Luis E Fayad,Sairah Ahmed,Ranjit Nair,Maria Alma Rodriguez,Paolo Strati,Dai Chihara,Christopher R Flowers, Linda Claret, Karina Liseth Ibanez, Michael L Wang, Nathan H Fowler, Jared Henderson, Richard Eric Davis, Sattva S Neelapu, Michael R Green,Loretta Nastoupil

Blood advances (2025)

Cited0Views0WOSBibtex

Outcomes with Bridging Radiation Therapy Prior to Chimeric Antigen Receptor T-cell Therapy in Patients with Aggressive Large B-cell Lymphomas

Gohar S Manzar,Chelsea C Pinnix, Stephanie O Dudzinski,Kathryn E Marqueen,Elaine E Cha,Lewis F Nasr,Alison K Yoder, Michael K Rooney,Paolo Strati,Sairah Ahmed,Chijioke Nze,Ranjit Nair,Luis E Fayad,Michael Wang,Loretta J Nastoupil, Jason R Westin,Christopher R Flowers, Sattva S Neelapu, Jillian R Gunther,Bouthaina S Dabaja,Susan Y Wu,Penny Q Fang

Frontiers in immunology (2025): 1517348-1517348

Cited0Views0WOSBibtex

Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed CNS Lymphomas

Dai Chihara,Raphael E Steiner,Ranjit Nair,Lei Feng,Sairah Ahmed,Paolo Strati,Luis Malpica, Donna P Griffith, Shivon A Mathew, Wirt Montinez,Gita Masand,Felipe Samaniego,Maria A Rodriguez,Fredrick B Hagemeister,Luis E Fayad,Swaminathan P Iyer,Loretta J Nastoupil,Sattva S Neelapu,Christopher R Flowers,Jason R Westin

Blood advancesno. 7 (2025): 1485-1491

Cited0Views0WOSBibtex

Clinical Factors Associated with Failure to Manufacture Commercial CAR-T Cell Products among LBCL Patients

Transplantation and Cellular Therapyno. 2 (2024): S214

Cited0Views0Bibtex

Risk Analysis of Cytokine Release Syndrome, Immune Effector Cell- Associated Neurotoxicity Syndrome, and Immune Effector Cell- Associated Hemophagocytic Lymphohistiocytosis-like Syndrome in BiTE Therapy Vs CAR-T Therapy Using Real World Data

Alexandra Elias,Rishab Prakash,Ranjit Nair,Luis Malpica,Hun Ju Lee, Eguono Maples, Samantha Carlson,Luis E. Fayad,Krina K. Patel,Sairah Ahmed,Swaminathan P Iyer

Bloodno. Supplement 1 (2024): 611-611

Cited0Views0Bibtex

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Hun Ju Lee,Gregory Ravizzini,Eslam Aboismail, Jenna Wixom,Jared Henderson,Luis E. Fayad,Sairah Ahmed,Ranjit Nair,Jason R. Westin, Swaminathan P. Lyer,Chijioke Nze,Ajlan Al Zaki,Francisco Vega,Michael Wang,Christopher R. Flowers,Luis Malpica

BLOOD (2024): 16743-16744

Cited0Views0Bibtex

P-291 Retrospective Review of Two Cases of Localized Iatrogenic Anakinra-Type Amyloidosis at the University of Texas MD Anderson Cancer Center

Frances Cervoni-Curet,Hans Lee,Luis Fayad, Brittany Weeks, Efe Ighovoyivwi,Melody Becnel

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2024): S203-S204

Cited0Views0Bibtex

Glofitamab in Combination with Rituximab Plus Ifosfamide, Carboplatin, and Etoposide Shows Favorable Efficacy and Manageable Safety in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Eligible for Stem Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: Results from a Phase Ib Study

Catherine S. Diefenbach, Paolo F. Caimi,Nakhle S Saba, Fernando Vargas Madueno,Mehdi Hamadani,Luis E. Fayad, Peter A. Riedell, Andrew Gillis-Smith,Stephen Simko, Victor Orellana-Noia, Maria Filippou-Frye,Amy V. Kapp,James Relf,Linda Lundberg,Lauren C. Pinter-Brown

Bloodno. Supplement 1 (2024): 987-987

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn